Literature DB >> 437588

Clinical use of reverse isolation in a protected environment.

M Bláha, J Vanásek, V Mĕrka, M Splino, J Malý, O Siroký.   

Abstract

The therapeutic method of reverse isolation in patients using an aseptic environment in the Life Island or Laminar Air Flow Unit apparatus systems is described on the basis of data from the literature and the authors' experience. A historical summary of views on treatment in an aseptic environment is followed by a description of the method of work with the system of reverse isolation, including important technical, operational and other data. The main indications for treatment are given and the authors' experience with the reverse isolation of 36 patients suffering from blood diseases who were treated in this way over the past four years is evaluated. The experience gained confirms data from the literature that reverse isolation is unequivocally successful in reducing the number of infections in immunologically weakened persons. Other aspects have not yet been definitely assessed.

Entities:  

Mesh:

Year:  1979        PMID: 437588     DOI: 10.1007/bf02927247

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  29 in total

1.  [Treatment of acute bone-marrow suppression in an aseptic environment].

Authors:  M Blăha; J Mazák; J Vanásek; Z Hrncír; V Mĕrka; O Stroký
Journal:  Vnitr Lek       Date:  1977-08

2.  [Prevention of infection in agranulocytosis: 1st experiences with patient isolation and whole body decontamination. Preliminary report].

Authors:  G A Nagel; R Martin; W Seiler; A C Mayr; A Koelz
Journal:  Schweiz Med Wochenschr       Date:  1974-01-26

3.  Design and use of plastic tents for isolation of patients prone to infection.

Authors:  A C Robertson; J Lynch; H E Kay; B Jameson; R J Guyer; I L Evans
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

4.  Reverse isolation in bone marrow transplantation: ultra-clean room compared with laminar flow technique. II. Microbiological and clinical results.

Authors:  J M Vossen; D van der Waay
Journal:  Rev Eur Etud Clin Biol       Date:  1972 Jun-Jul

5.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

6.  Pathogen-free isolation unit--three years' experience.

Authors:  M Schneider; L Schwarzenberg; J L Amiel; A Cattan; J R Schlumberger; M Hayat; F De Vassal; C Jasmin; C Rosenfeld; G Mathé
Journal:  Br Med J       Date:  1969-03-29

7.  Antibiotics alter methotrexate metabolism and excretion.

Authors:  D S Zaharko; H Bruckner; V T Oliverio
Journal:  Science       Date:  1969-11-14       Impact factor: 47.728

8.  [Use of patient isolators in the intensive chemotherapy of acute leukemia].

Authors:  M Dietrich; T M Fliedner; H Heimpel
Journal:  Verh Dtsch Ges Inn Med       Date:  1969

9.  Studies of patients in a laminar air flow unit.

Authors:  G P Bodey; E J Freireich; E Frei
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

10.  Patient protection in cancer chemotherapy.

Authors:  S A Schwartz; S Perry
Journal:  JAMA       Date:  1966-08-22       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.